Download PDF
Z Gastroenterol 2001; 39(4): 311-320
DOI: 10.1055/s-2001-12872
Übersicht
© Karl Demeter Verlag im Georg Thieme Verlag Stuttgart · New York

Extragastrale Manifestationen einer H.-pylori-Infektion

Extragastric manifestations of H. pylori infectionP. C. Konturek, E. G. Hahn
  • Priv.-Doz. Dr. med. Peter Konturek, Medizinische Klinik I (Direktor Prof. Dr. E. G. Hahn), Universität Erlangen-Nürnberg
Further Information

Publication History

9.3.2000

5.6.2000

Publication Date:
31 December 2001 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

In letzter Zeit wurde man auf mögliche Assoziationen zwischen der Infektion mit Helicobacter pylori und extragastralen Erkrankungen aufmerksam. Dabei handelt es sich um ein breites Spektrum von verschiedenen Erkrankungen wie Gefäßerkrankungen, Hauterkrankungen, Autoimmunerkrankungen, Nahrungsmittelallergie, Lebererkrankungen, hämatologische Erkrankungen, Diabetes mellitus, pädiatrische Erkrankungen (z. B. plötzlicher Kindstod, Wachstumsstörungen) extragastrale MALT-Lymphome und sogar kolorektale Karzinome. Eine potenzielle Rolle von H. pylori bei der Auslösung von extragastralen Erkrankungen stützt sich auf folgende Beobachtungen: 1. die Infektion mit H. pylori löst nicht nur eine chronische Entzündung in der Magenschleimhaut aus, sondern geht auch mit einer systemischen Immunantwort einher; 2. im Rahmen der Gastritis werden verschiedene entzündliche Mediatoren ins Blut abgegeben, die Erkrankungen außerhalb des Magens auslösen können; 3. eine erfolgreiche Eradikationstherapie führt zur partiellen oder kompletten Remission der extragastralen Erkrankungen. Die bisher publizierten Studien liefern zum Teil sehr widersprüchliche Ergebnisse, die durch verschiedene Störfaktoren in den epidemiologischen Studien erklärbar sind. Anhand der derzeit verfügbaren Daten konnte keine dieser Assoziationen gesichert werden, was die Notwendigkeit weiterer prospektiver Studien zur endgültigen Klärung der Rolle von H. pylori bei der Entstehung von extragastralen Erkrankungen unterstützt.

Extragastric manifestations of H. pylori infection

Recently, H. pylori has been associated with several extradigestive diseases such as cardio-vascular, cutaneous, autoimmune, allergic, liver, hematologic disorders, diabetes mellitus, pediatric diseases (sudden infant death syndrome, growth retardation), extragastric MALT-type lymphomas and even colorectal cancer. The potential role of H. pylori infection in the pathogenesis of these extradi­gestive disorders has been based on the follow­ing facts: 1) local gastric infection with H. pylori may exert systemic effects; 2) during chronic H. pylori induced gastritis several different inflammatory mediators are released that are able to cause disorders remote to the primary site of infection and 3) the successful eradication of H. pylori infection improves partly or completely the extradigestive disorders. The available data is conflicting because of the presence of several confound­ing factors in epidemiological studies. On the basis of the published data any of these associations has been proved. Further prospective studies to explain the association between H. pylori and extradigestive disorders are needed.

Schlüsselwörter

Helicobacter pylori - extragastrale Erkrankungen

Key words

Helicobacter Pylori - Extragastric Manifestations

Literatur

  • 1 Marshall J, Warren J R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration.  Lancet. 1984;  1 1311-1314
    Google Scholar
  • 2 Pounder R E. The prevalence of Helicobacter pylori infection in different countries.  Alim Pharmacol Ther. 1995;  9 (Suppl. 2) 33-39
    Google Scholar
  • 3 Isaacson P G, Spencer J. Is gastric lymphoma an infectious disease?.  Hum Pathol. 1993;  24 569-570
    Google Scholar
  • 4 Huang J Q, Sridhar S, Chen Y, Hunt R H. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer.  Gastroenterology. 1998;  114 1169-1179
    Google Scholar
  • 5 Gasbarrini A, Francheschi F, Armuzzi. et al . Extradigestive manifestations of Helicobacter pylori infection.  Gut. 1999;  45 I9-I12 (Suppl I)
    Google Scholar
  • 6 Ernst P B, Crowe S E, Reyes V E. et al . How does Helicobacter pylori cause mucosal damage? The inflammatory response.  Gastroenterology. 1997;  113 35-42
    Google Scholar
  • 7 Thomas J E, Dole A, Harding M. et al . Pediatr. H. pylori colonization in early life.  Res. 1999;  45 218-223
    Google Scholar
  • 8 Bagchi D, Bhattacharya G, Stohs S J. Production of reactive oxygen species by gastric cells in association with H. pylori.  Free Radic Res. 1996;  24 439-450
    Google Scholar
  • 9 Shimoyama T, Everett S M, Dixon M F. et al . Chemokine mRNA expression in gastric mucosa is associated with Helicobacter pylori cagA positivity and severity of gastritis.  J Clin Pathol. 1998;  51 765-770
    Google Scholar
  • 10 Huseyinov A, Kutukculer N, Aydogdu S. et al . Increased gastric production of platelet-activating factor, leukotriene-B4, and tumor necrosis factor-alpha in children with Helicobacter pylori infection.  Dig Dis Sci. 1999;  44 675-679
    Google Scholar
  • 11 Romano M, Ricci V, Memoli A. et al . Helicobacter pylori up-regulates cyclooxygenase-2 mRNA expression and prostaglandin E2 synthesis in MKN 28 gastric mucosal cells in vitro.  J Biol Chem. 1998;  273 28 560-28 563
    Google Scholar
  • 12 Hudson N, Balsitis M, Filipowicz F. et al . Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking nonsteroidal antiinflammatory dugs.  Gut. 1993;  34 748-751
    Google Scholar
  • 13 Velasquez R D, Brunner G, Varrentrapp M. et al . Helicobacter pylori produces histamine and spermidine.  Z Gastroenterol. 1996;  34 116-122
    Google Scholar
  • 14 Figura N. Helicobacter pylori factors involved in the development of gastroduodenal mucosal damage and ulceration.  J Clin Gastroenterol. 1997;  25 (Suppl. 1) 149-163
    Google Scholar
  • 15 Quaschning T, Ruschitzka F T, Maier W. et al . Die Rolle des Endothels bei der Entstehung und Behandlung von Gefäßerkrankungen.  Internist. 2000;  41 355-262
    Google Scholar
  • 16 Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: Is there a link?.  Lancet. 1997;  350 430-436
    Google Scholar
  • 17 Kuo C, Shor A, Campbell L. et al . Demonstration of Chlamydia pneumoniae in artheriosclerotic lesions of coronary arteries.  J Infect Dis. 1993;  167 841-849
    Google Scholar
  • 18 Kaner R J, Hajjar D P. Viral activation of thrombo-atherosclerosis. Fuster V, Ross R, Topol EJ Lippinott-Raven Athero­sclerosis and coronary artery disease Philadelphia; 1996: 569-584
    Google Scholar
  • 19 H S ternby. Atherosclerosis and peptic ulcer.  Bull WHO. 1976;  53 571-577
    Google Scholar
  • 20 Mendall M A, Goggin P M, Molineaux N. et al . Relation of Helicobacter pylori infection and coronary heart disease.  Br Heart J. 1994;  71 437-439
    Google Scholar
  • 21 Mendall M A, Patel P, Asante M. et al . Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease.  Heart. 1997;  78 273-277
    Google Scholar
  • 22 Lagrand W K, Visser C A, Hermens W T. et al . C-reactive protein as a cardiovascular risk factor.  Circulation. 1999;  100 96-102
    Google Scholar
  • 23 Torgano G, Cosentini R, Mandelli C. et al . Treatment of Helicobacter pylori and Chlamydia pneumoniae infections decreases fibrinogen plasma level in patients with ischemic heart disease.  Circulation. 1999;  99 1555-1559
    Google Scholar
  • 24 Bhagat K, Moss R, Collier J, Vallance P. Endothelial „stunning” following brief exposure to endotoxin: A mechanism to link infection and infarction?.  Cardiovasc Res. 1996;  32 822-829
    Google Scholar
  • 25 Laurila A, Bloigu A, Nayha S. et al . Association of Helicobacter pylori infection with elevated serum lipids.  Atherosclerosis. 1999;  142 207-210
    Google Scholar
  • 26 Birnie D H, Holme E R, McKay I C. et al . Association between antibodies to heat shock protein 65 and coronary athero­sclerosis. Possible mechanism of action of H. pylori and other bacterial infections in increasing cardiovascular risk.  Eur Heart J. 1998;  19 387-394
    Google Scholar
  • 27 Sung J J, Sanderson J E. Hyperhomocysteinaemia, Helicobacter pylori and coronary heart disease.  Heart. 1996;  76 305-307
    Google Scholar
  • 28 Pasceri V, Cammarota G, Patti G. et al . Association of virulent Helicobacter pylori strains with ischemic heart disease.  Circulation. 1998;  97 1675-1679
    Google Scholar
  • 29 Ossei-Gerning N, Moayyyedi P, Smith S. et al . Helicobacter pylori infection is related to atheroma in patients undergoing coronary angiography.  Cardiovasc Res. 1997;  35 120-124
    Google Scholar
  • 30 Pieniazek P, Karczewska E, Duda A. et al . Association of Helicobater pylori infection with coronary heart disease.  J Physiol Pharmacol. 1999;  50 743-751
    Google Scholar
  • 31 Martin-de-Argila C, Boixeda D, Canton R. et al . High seroprevalence of Helicobacter pylori infection in coronary heart disease.  Lancet. 1995;  346 310
    Google Scholar
  • 32 Whincup P H, Mendall M A, Perry I J. et al . Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men.  Heart. 1996;  75 568-572
    Google Scholar
  • 33 Patel P, Mendall M A, Carrington D. et al . Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors.  BMJ. 1995;  3111 711-714
    Google Scholar
  • 34 Danesh J, Youngman L, Clark S. et al . Helicobacter pylori infection and early onset myocardial infarction: Case-control and sibling pairs study.  BMJ. 1999;  319 1157-1162
    Google Scholar
  • 35 De Luis D A, Lahera M, Canton R. et al . Association of Helicobacter pylori infection with cardiovascular and cerebrovascular disease in diabetic patients.  Diabetes Care. 1998;  21 1129-1132
    Google Scholar
  • 36 Pellicano R, Mladenova I, Broutet N. et al . Is there an association between Helicobacter pylori infection and coronary heart disease.  Eur J Epidemiol. 1999;  15 611-619
    Google Scholar
  • 37 Niemela S, Karttunen T, Korhonen T. et al . Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations?.  Heart. 1996;  75 573-575
    Google Scholar
  • 38 McDonagh T A, Woodward M, Morrison C E. et al . Helicobacter pylori infection and coronary heart disease in the North Glasgow MONICA population.  Eur Heart J. 1997;  18 1257-1260
    Google Scholar
  • 39 Danesh J, Wong Y, Ward M. et al . Chronic infection with Helicobacter pylori, Chlamydia pneumoniae, or cytomegalovirus: Population based study of coronary disease.  Heart. 1999;  81 245-247
    Google Scholar
  • 40 Quinn M J, Foley J B, Mulvihill N T. et al . Helicobacter pylori serology in patients with angiographically documented coronary artery disease.  Am J Cardiol. 1999;  83 1664-1666
    Google Scholar
  • 41 Koenig W, Rothenbacher D, Hoffmeister A. et al . Infection with Helicobacter pylori is not a major independent risk factor for stable coronary heart disease: Lack of a role of cytotoxin-associated protein A-positive strains and absence of a systemic inflammatory response.  Circulation. 1999;  100 2326-2331
    Google Scholar
  • 42 Basili S, Vieri M, Di Lecce V N. et al . Association between histological diagnosis of Helicobacter pylori and coronary heart disease: Result of a retrospective study.  Clin Ther. 1998;  149 413-417
    Google Scholar
  • 43 Rathbone B, Martin D, Stephens J. et al . Helicobacter pylori seropositivity in subjects with acute myocardial infarction.  Heart. 1996;  76 308-311
    Google Scholar
  • 44 Folsom A R, Nieto F J, Sorlie P. et al . Helicobacter pylori seropositivity and coronary heart disease incidence. Atherosclerosis Risk in Communities (ARIC) Study Investigators.  Circulation. 1998;  98 845-850
    Google Scholar
  • 45 Whincup P, Danesh J, Walker M. et al . Prospective study of potentially virulent strains of Helicobacter pylori and coronary heart disease in middle-aged men.  Circulation. 2000;  101 1647-1652
    Google Scholar
  • 46 Danesh J, Peto R. Risk factors for coronary heart disease and infection with Helicobacter pylori: Metaanalysis of 18 studies.  BMJ. 1998;  16 1130-1132
    Google Scholar
  • 47 Markus H S, Mendall M A. Helicobacter pylori infection: A risk factor for ischemic cerebrovascular disease and carotid atheroma.  J Neurol Neurosurg Psychiatry. 1998;  64 104-107
    Google Scholar
  • 48 Gasbarrini A, De Luca A, Fiore G. et al . Beneficial effects of Helicobacter pylori eradication on migraine.  Hepatogastroenter­ology. 1998;  45 765-770
    Google Scholar
  • 49 Hatz R A, Meimarakis G, Lehn G. et al . Granulocyte activation by Helicobacter pylori.  Eur J Med Res. 1996;  1 537-542
    Google Scholar
  • 50 Denizot Y, Sobhani I, Rambaud J C. et al . Paf-acether synthesis by Helicobacter pylori.  Gut. 1990;  31 1242-1245
    Google Scholar
  • 51 Elizalde J I, Gomez J, Lozano M. et al . Platelet activation in mice and human Helicobacter pylori infection.  J Clin Invest. 1997;  100 996-1005
    Google Scholar
  • 52 Gasbarrini A, Massari I, Serricchio M. et al . Helicobacter pylori eradication ameliorates primary Raynaud’s phenomenon.  Dig Dis Sci. 1998;  43 1641-1645
    Google Scholar
  • 53 Faller G, Steininger H, Appelmelk B, Kirchner T. Evidence of novel pathogenic pathways for the formation of antigastric autoantibodies in Helicobacter pylori gastritis.  J Clin Pathol. 1998;  51 244-245
    Google Scholar
  • 54 Claeys D, Faller G, Appelmelk B J, Negrini R, Kirchner T. The gastric H+,K+ ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy.  Gas­troenterology. 1998;  115 340-347
    Google Scholar
  • 55 Figura N, Di Cairano G, Lorc F. et al . The infection by Helicobacter pylori strains expressing CagA is highly prevalent in women with autoimmune thyroid disorders.  J Physiol Pharmacol. 1999;  50 807-817
    Google Scholar
  • 56 Aragona P, Magazzu G, Macchia G. et al . Presence of antibodies against Helicobacter pylori and its heat-shock protein 60 in the serum of patients with Sjögren‘s syndrome.  J Rheumatol. 1999;  26 1306-1311
    Google Scholar
  • 57 Gasbarrini A, Francheschi F, Tartaglione R. et al . Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori.  Lancet. 1998;  352 878
    Google Scholar
  • 58 Reinauer S, Megahed M, Gerz G. Schönlein-Henoch purpura associated with gastric Helicobacter pylori infection.  J Am Acad Dermatol. 1995;  33 876-879
    Google Scholar
  • 59 Corrado G, Luzzi I, Lucarelli S. et al . Positive association between Helicobacter pylori infection and food allergy in children.  Scand J Gastroenterol. 1998;  33 1135-1139
    Google Scholar
  • 60 Figura N, Perrone A, Gennari C. et al . Food allergy and Helicobacter pylori infection.  Ital J Gastroenterol Hepatol. 1999;  31 186-191
    Google Scholar
  • 61 Matysiak-Budnik T, Hashimoto K, Heyman M. et al . Antral gastric permeability to antigens in mice is altered by infection with Helicobacter felis.  Eur J Gastroenterol Hepatol. 1999;  11 1371-1377
    Google Scholar
  • 62 Matysiak-Budnik T, Terpend K, Alain S. et al . Helicobacter pylori alters exogenous antigen absorption and processing in a digestive tract epithelial cell line model.  Infect Immun. 1998;  66 785-791
    Google Scholar
  • 63 Wedi B, Wagner S, Werfel T, Manns M P, Kapp A. Prevalence of Helicobacter pylori-associated gastritis in chronic urtikaria.  Int Arch Allergy Immunol. 1997;  116 288-294
    Google Scholar
  • 64 Di Campli C, Gasbarrini A, Nucera E. et al . Beneficial effects of Helicobacter pylori eradication on idiopathic chronic urtikaria.  Dig Dis Sci. 1998;  43 1226-1229
    Google Scholar
  • 65 Wustlich S, Brehler R, Luger T A. et al . Helicobacter pylori as a possible bacterial focus of chronic urtikaria.  Dermatology. 1999;  198 130-132
    Google Scholar
  • 66 Kolibasova K, Tuthova I, Baumgartner J, Filo V. Eradication of H. pylori as the only successful treatment in rosacea.  Arch Dermatol. 1996;  132 1393
    Google Scholar
  • 67 Pytko-Polonczyk J, Szlachcic A, Sliwowski Z. et al . Helicobacter pylori infection in rosacea.  Gut. 1999;  45 A88 (Suppl III)
    Google Scholar
  • 68 Powell F C, Daw M A, Duguid C. Positive Helicobacter pylori serology in rosacea patients.  PD. 1992;  12
    Google Scholar
  • 69 Jones M P, Knable A L, White M J, Durning S J. Helicobacter pylori in rosacea: Lack of an association.  Arch Dermatol. 1998;  134 511
    Google Scholar
  • 70 Fox J G, Dewhirst F E, Shen Z. et al . Helicobacter pylori species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis.  Gastroenterology. 1998;  114 755-763
    Google Scholar
  • 71 Nilsson H O, Teneera J, Casteda M, Olsson R, Wadström T. Detection of Helicobacter by PCR and DNA hybridization in human liver samples from patients with primary sclerosing cholangitis and primary biliary cirrhosis.  Gut. 1999;  45 A1 (Suppl III)
    Google Scholar
  • 72 Nilsson I, Lindgren S, Eriksson S, Wadström T. Serum antibodies to Helicobacter hepaticus and Helicobacter pylori in patients with chronic liver disease.  Gut. 2000;  46 410-414
    Google Scholar
  • 73 Figura N, Cetta F, Angelico M. et al . Most Helicobacter pylori-infected patients have specific antibodies, and some also have H. pylori antigens and genomic material in bile.  Dig Dis Sci. 1998;  43 854-862
    Google Scholar
  • 74 Siringo S, Vaira D, Menegatti M. et al . High prevalence of Helicobacter pylori in liver cirrhosis: Relationship with clinical and endoscopic features and the risk of peptic ulcer.  Dig Dis Sci. 1997;  42 2024-2030
    Google Scholar
  • 75 Dasani B M, Sigal S H, Lieber C S. Analysis of risk factors for chronic hepatic encephalopathy: The role of Helicobacter pylori infection.  Am J Gastroenterol. 1998;  93 726-731
    Google Scholar
  • 76 Ito S, Miyaji H, Azuma T. et al . Hyperammonemia and H. pylori (letter).  Lancet. 1995;  346 124-125
    Google Scholar
  • 77 Zullo A, Rinaldi V, Folino S, Diana F, Attili A. Helicobacter pylori urease inhibition and ammonia levels in cirrhotic patients.  Am J Gastroenterol. 1998;  93 851-852
    Google Scholar
  • 78 Suto H, Ito S, Azuma T. et al . Helicobacter pylori infection induces hyperammonemia in mongolian gerbils with fatty cirrhosis.  Gut. 1999;  45 A87 (Suppl. III)
    Google Scholar
  • 79 Vasconez C, Elizalde J I, Llach J. et al . Helicobacter pylori, hyperammonemia and subclinical encephalopathy: Effects of eradication.  J Hepatol. 1999;  30 260-264
    Google Scholar
  • 80 Oldenburg B, Diepersloot R J, Hoekstra J B. High seroprevalence of Helicobacter pylori in diabetes mellitus patients.  Dig Dis Sci. 1996;  41 458-461
    Google Scholar
  • 81 de Luis D A, de la Calle H, Roy G. et al . Helicobacter pylori infection and insulin-dependent diabetes mellitus.  Diabetes Res Clin Pract. 1998;  39 143-146
    Google Scholar
  • 82 Gasbarrini A, Ojetti V, Pitocco D. et al . Helicobacter pylori infection in patients affected by insulin-dependent diabetes mellitus.  Eur J Gastroenterol Hepatol. 1998;  10 496-472
    Google Scholar
  • 83 Gasbarrini A, Ojetti V, Pitocco D. et al . Efficacy of different Helicobacter pylori eradication regimes in patients affected by insulin-dependent diabetes mellitus.  Scand J Gastroenterol. 2000;  35 260-263
    Google Scholar
  • 84 Mégraud F. Resistance of H. pylori to antibiotics.  Aliment Pharmacol Ther. 1997;  11 43-53
    Google Scholar
  • 85 Gwilt P R, Nahhas R R, Tracewell W G. The effects of diabetes mellitus on pharmacokinetics and pharmadynamics in humans.  Clin Pharmacokinet. 1991;  20 477-490
    Google Scholar
  • 86 Tooke J. Microvascular haemodynamics in diabetes mellitus.  Clin Sci. 1986;  70 119-125
    Google Scholar
  • 87 Horowitz M, Wishart J M, Jones K L, Hebbard G S. Gastric emptying in diabetes: An overview.  Diab Med. 1996;  13 S16-S22
    Google Scholar
  • 88 de Luis D A, Garcia A, Lasuncion M A. et al . Improvement in lipid and haemostasis patterns after H. pylori infection eradication in type 1 diabetic patients.  Clin Nutr. 1999;  18 227-231
    Google Scholar
  • 89 Annibale B, Marignani M, Monarca B. et al . Reversal of iron deficiency anemia after Helicobacter pylori eradication in patients with asymptomatic gastritis.  Ann Intern Med. 1999;  131 668-672
    Google Scholar
  • 90 Husson M O, Legrand D, Spik G, Leclerc H. Iron acquisition by Helicobacter pylori: Importance of human lactoferrin.  Infect Immun. 1993;  61 2694-2697
    Google Scholar
  • 91 Zhang Z W, Patchett S E, Perrett D. et al . The relation between gastric vitamin C concentrations, mucosal histology, and CagA seropositivity in the human stomach.  Gut. 1998;  43 322-326
    Google Scholar
  • 92 Choe Y H, Kim S K, Hong Y C. Helicobacter pylori infection with iron deficiency anemia and subnormal growth at puberty.  Arch Dis Child. 2000;  82 136-140
    Google Scholar
  • 93 Patel P, Mendall M A, Khulusi S, Northfield T C, Strachan D P. Helicobacter pylori infection in childhood: Risk factors and effect on growth.  BMJ. 1994;  309 1119-1123
    Google Scholar
  • 94 Perri F, Pastore M, Gleandro G, Clemente R. et al . Helicobacter pylori infection and growth delay in older children.  Arch Dis Child. 1997;  77 46-49
    Google Scholar
  • 95 Oderda G, Palli D, Saieva C, Chiorboli C, Bona G. Short stature and Helicobacter pylori infection in Italian children: prospec­tive multicenter hospital based case-control study.  BMJ. 1998;  317 514-515
    Google Scholar
  • 96 Cacciari E, Menegatti M, Salardi S. et al . Helicobacter pylori infection and cytotoxin antigen associated gene A status in short children.  J Pediatr Endocrinol Metab. 1999;  12 197-201
    Google Scholar
  • 97 Cote A, Russo P, Michaud J. Sudden unexpected deaths in infancy: What are the causes?.  J Pediatr. 1999;  135 437-443
    Google Scholar
  • 98 Pattison C P, Marshall B J. Proposed link between Helicobacter pylori and sudden infant death syndrome.  Med Hypotheses. 1997;  49 365-369
    Google Scholar
  • 99 Forsyth K D. Immune and inflammatory responses in sudden infant death syndrome.  FEMS Immunol Med Microbiol. 1999;  25 79-83
    Google Scholar
  • 100 Altschuler E. Gastric Helicobacter pylori infection as a cause of idiopathic Parkinson disease and non-arteric anterior optic ischemic neuropathy.  Med Hypotheses. 1996;  47 413-414
    Google Scholar
  • 101 Chiba S, Sugiyama T, Matsumoto H. et al . Antibodies against Helicobacter pylori were detected in the cerebrospinal fluid obtained from patients with Guillain-Barré syndrome.  Ann Neurol. 1998;  44 686-688
    Google Scholar
  • 102 Breuer-Katschinski B, Nemes K, Marr A. et al . Colorectal Adenoma Study Group. Helicobacter pylori and the risk of colonic adenomas.  Digestion. 1999;  60 210-215
    Google Scholar
  • 103 Singh P, Dai B, Wu H, Owlia A. Role of autocrine and endocrine gastrin-like peptides in colonic carcinogenesis.  Curr Opin Gastroenterol. 2000;  16 68-77
    Google Scholar
  • 104 Mulholland G, Ardill J E, Fillmore D. et al . Helicobacter pylori related hypergastrinemia is the result of selective increase in gastrin 17.  Gut. 1993;  34 757-761
    Google Scholar
  • 105 Rederer M, Pfeffel F, Pohl G. et al . Regression of colonic low grade B cell lymphoma of the mucosa associated lymphoid tissue type after eradication of H. pylori.  Gut. 2000;  46 133-135
    Google Scholar

Anschrift für die Verfasser

Priv.-Doz. Dr. med. Peter Konturek

Medizinische Klinik I
Universität Erlangen-Nürnberg

Krankenhausstraße 12

91054 Erlangen

Fax: 0 91 31/8 53 69 09

Email: Peter.Konturek@med1.imed.uni-erlangen.de